Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Charles B. Nemeroff, MD, PhD: Overview of the Safety of Citalopram
1
x
$
30.00
C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
1
x
$
30.00
Long-Term Treatment Strategies in Affective Disorders
1
x
$
30.00
Patient Health Questionnaire
1
x
$
0.00
Treatment of Autism Spectrum Disorder in Children and Adolescents
1
x
$
30.00
C. Lindsay DeVane, PharmD: Clinical Significance of Drug Binding, Protein Binding, and Binding Displacement Drug Interactions
1
x
$
30.00
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
1
x
$
30.00
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
1
x
$
30.00
Escitalopram: A Second-Generation SSRI
1
x
$
0.00
Madhukar H. Trivedi - Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design
1
x
$
30.00
Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder
1
x
$
30.00
Mark Zetin, MD: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients
1
x
$
30.00
Theodore J. Anfinson, MD: Akathisia, Panic, Agoraphobia, and Major Depression Following Brief Exposure to Metoclopramide
1
x
$
30.00
Divalproex in the Treatment of Migraine
1
x
$
30.00
View Cart
Checkout
Home
venlafaxine
You cannot add another "New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD" to your cart.
View cart
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Raising the Bar From Response to Remission in the Therapy of Generalized Anxiety Disorder
$
10.00
Add to cart
Details
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Affective Disorders
$
30.00
Add to cart
Details
Generalized Anxiety Disorder: Raising the Expectations of Treatment
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Coping With Somatic Comorbidities: Striving for Complete Recovery
$
30.00
Add to cart
Details
Mechanism of Action of Antidepressants
$
30.00
Add to cart
Details
Depression Treatment: A Lifelong Commitment?
$
30.00
Add to cart
Details
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
$
30.00
Add to cart
Details
Can We Distinguish Anxiety From Depression?
$
30.00
Add to cart
Details
C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
$
30.00
Add to cart
Details
Effects of Venlafaxine on the Size of Brain and Expression of SHANK3, TUBB5 and DDC Genes in BALB/c Mice
$
30.00
Add to cart
Details
Page load link
Go to Top
